DU-176b Phase III Clinical Study (Venous Thromboembolism) Randomized Double-Blind Study of DU-176b in Patients Undergoing Total Hip Arthroplasty with Enoxaparin as an Active Control
Phase 3
- Conditions
- Patients undergoing total hip arthroplasty
- Registration Number
- JPRN-jRCT2080220743
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Patients undergoing unilateral total hip arthroplasty
Exclusion Criteria
-Subjects with risks of hemorrhage
-Subjects with thromboembolic risks
-Subjects who weigh less than 40 kg
-Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method